|
JPH09238615A
|
|
Health nutritive food
|
|
JPH09154435A
|
|
Model mouse for rheumatoid arthritis
|
|
JPH09151197A
|
|
Therapeutic agent for autoimmune disease
|
|
JPH09143097A
|
|
Efficacy assessment of medicine for anti-osteoarthropathy
|
|
JPH09127119A
|
|
Treatment effect judgement method for c-type chronic hepatitis
|
|
JPH09124503A
|
|
Antimicrobial composition for injection of amythiamicins
|
|
JPH08208489A
|
|
Therapeutic agent for renal failure
|
|
JPH08191880A
|
|
Deodorant
|
|
JPH0812576A
|
|
Anti-helicobacter pylori agent
|
|
JPH07330614A
|
|
Fat emulsion for transduction of gene into cell
|
|
JPH07324035A
|
|
Agent for suppressing proliferation of synoviocyte and agent for treatment of rheumatoid arthritis
|
|
JPH07289288A
|
|
Method for evaluating effect of antirheumatic medicine
|
|
JPH07188280A
|
|
Phosphatidylethanolamine-bonding physiologically active substance and its intermediate
|
|
JPH07188046A
|
|
External medicine containing cyclosporine and its production
|
|
JPH07145062A
|
|
Synovial cell proliferation suppressant and therapeutic agent for chronic articular pheumatism
|
|
JPH07115978A
|
|
Method for detecting and cloning antibody gene
|
|
JPH06296490A
|
|
Dna coding positively charged antibody causing sle nephritis
|
|
JPH06256182A
|
|
External pharmaceutical preparation
|
|
JPH06258319A
|
|
Test paper for detection of oxypurine in urine
|
|
JPH06157345A
|
|
Novel antibody for therapy of autoimmune disease
|
